Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019

SELL
$219.29 - $241.72 $2,631 - $2,900
-12 Closed
0 $0
Q4 2018

Feb 26, 2019

SELL
$278.5 - $352.75 $2,506 - $3,174
-9 Reduced 42.86%
12 $4,000
Q2 2018

Aug 10, 2018

BUY
$257.52 - $306.91 $2,575 - $3,069
10 Added 90.91%
21 $6,000
Q2 2017

Aug 10, 2017

BUY
N/A
11
11 $3,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Omnia Family Wealth, LLC Portfolio

Follow Omnia Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omnia Family Wealth, LLC with notifications on news.